在心力衰竭患者住院治疗中,白蛋白校正的阴离子间隙与死亡率之间的关系
Sidar Şiyar Aydın1, Emrah Aksakal1
1Cardiology, Erzurum City Hospital, Erzurum, TUR.
Cureus
|October 30, 2023
概括
蛋白校正的离子间隙 (ACAG) 是住院心力衰竭 (HF) 患者死亡率的重要预测因素. 较高的ACAG水平表明风险增加,有助于识别重症患者.
科学领域:
- 心脏病学 心脏病学
- 临床生物化学 临床生物化学
背景情况:
- 心力衰竭 (HF) 带来了显著的发病率和死亡率挑战.
- 需要新的生物标志物来识别高风险的住院HF患者.
- 这项研究调查了白蛋白校正的离子间隙 (ACAG) 作为高风暴死亡率预测因子.
研究的目的:
- 检查心力衰竭住院患者中ACAG和死亡率之间的关联.
- 确定ACAG是否可以作为该人群中死亡率的独立预测指标.
主要方法:
- 对205名住院高温肺炎患者 (2015-2022) 的回顾性分析.
- 收集的临床,血液学和生物化学数据,包括ACAG计算.
- 从国家死亡登记处获得的死亡率数据.
主要成果:
- 在非幸存者中观察到较高的血清离子间隙 (SAG) 和ACAG水平 (p=0.043,p=0.012).
- ACAG独立地预测了HF死亡率 (Cox回归,p=0.003).
- ACAG显示出良好的预测性能 (AUC 0.773,切断值13,75%的灵敏度,75.9%的特异性).
结论:
- 升高的ACAG显著与住院HF患者的死亡率增加有关.
- ACAG成为HF死亡风险分层的有价值的独立预测指标.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.9K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
